BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34201208)

  • 1. The Role of Anthocyanins, Deoxyanthocyanins and Pyranoanthocyanins on the Modulation of Tyrosinase Activity: An In Vitro and In Silico Approach.
    Correia P; Oliveira H; Araújo P; Brás NF; Pereira AR; Moreira J; de Freitas V; Mateus N; Oliveira J; Fernandes I
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Luteolinidin and Petunidin 3-
    Yang SY; Kim JH; Su X; Kim JA
    Molecules; 2022 Sep; 27(17):. PubMed ID: 36080469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of small-molecule inhibitors of tyrosinase.
    Germanas JP; Wang S; Miner A; Hao W; Ready JM
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6871-5. PubMed ID: 17964155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, molecular docking studies of coumarinyl-pyrazolinyl substituted thiazoles as non-competitive inhibitors of mushroom tyrosinase.
    Saeed A; Mahesar PA; Channar PA; Abbas Q; Larik FA; Hassan M; Raza H; Seo SY
    Bioorg Chem; 2017 Oct; 74():187-196. PubMed ID: 28837887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA; Saeed A; Larik FA; Rafiq M; Ashraf Z; Jabeen F; Fattah TA
    Bioorg Med Chem; 2017 Nov; 25(21):5929-5938. PubMed ID: 28988751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of tyrosinase-cyanidin-3-O-glucoside and (-/+)-catechin binding modes reveal mechanistic differences in tyrosinase inhibition.
    Lee KE; Bharadwaj S; Sahoo AK; Yadava U; Kang SG
    Sci Rep; 2021 Dec; 11(1):24494. PubMed ID: 34969954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, computational molecular docking analysis and effectiveness on tyrosinase inhibition of kojic acid derivatives.
    Karakaya G; Türe A; Ercan A; Öncül S; Aytemir MD
    Bioorg Chem; 2019 Jul; 88():102950. PubMed ID: 31075740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers.
    Larik FA; Saeed A; Channar PA; Muqadar U; Abbas Q; Hassan M; Seo SY; Bolte M
    Eur J Med Chem; 2017 Dec; 141():273-281. PubMed ID: 29040952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Amide Derivatives as Potent Tyrosinase Inhibitors; In-vitro, In-vivo Antimelanogenic Activity and Computational Studies.
    Ali A; Ashraf Z; Rafiq M; Kumar A; Jabeen F; Lee GJ; Nazir F; Ahmed M; Rhee M; Choi EH
    Med Chem; 2019; 15(7):715-728. PubMed ID: 30892163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors:
    Sabuakham S; Nasoontorn S; Kongtaworn N; Rungrotmongkol T; Silsirivanit A; Pingaew R; Mahalapbutr P
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2357174. PubMed ID: 38814149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
    Bagherzadeh K; Shirgahi Talari F; Sharifi A; Ganjali MR; Saboury AA; Amanlou M
    J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and bioevaluation of novel umbelliferone analogues as potential mushroom tyrosinase inhibitors.
    Ashraf Z; Rafiq M; Seo SY; Babar MM; Zaidi NU
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):874-83. PubMed ID: 25643758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Based Design, Synthesis, Biological Evaluation and Molecular Docking Study of 4-Hydroxy-N'-methylenebenzohydrazide Derivatives Acting as Tyrosinase Inhibitors with Potentiate Anti-Melanogenesis Activities.
    Iraji A; Khoshneviszadeh M; Bakhshizadeh P; Edraki N; Khoshneviszadeh M
    Med Chem; 2020; 16(7):892-902. PubMed ID: 31339074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, molecular docking and kinetic studies of novel quinolinyl based acyl thioureas as mushroom tyrosinase inhibitors and free radical scavengers.
    Mustafa MN; Saeed A; Channar PA; Larik FA; Zain-Ul Abideen M; Shabir G; Abbas Q; Hassan M; Raza H; Seo SY
    Bioorg Chem; 2019 Sep; 90():103063. PubMed ID: 31220666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tyrosinase inhibitory effects of isoxazolone derivatives with a (Z)-β-phenyl-α, β-unsaturated carbonyl scaffold.
    Kim SJ; Yang J; Lee S; Park C; Kang D; Akter J; Ullah S; Kim YJ; Chun P; Moon HR
    Bioorg Med Chem; 2018 Aug; 26(14):3882-3889. PubMed ID: 29907470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory properties of aromatic thiosemicarbazones on mushroom tyrosinase: Synthesis, kinetic studies, molecular docking and effectiveness in melanogenesis inhibition.
    Hałdys K; Goldeman W; Jewgiński M; Wolińska E; Anger N; Rossowska J; Latajka R
    Bioorg Chem; 2018 Dec; 81():577-586. PubMed ID: 30248509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Heptapeptide with Tyrosinase Inhibitory Activity Identified from a Phage Display Library.
    Nie H; Liu L; Yang H; Guo H; Liu X; Tan Y; Wang W; Quan J; Zhu L
    Appl Biochem Biotechnol; 2017 Jan; 181(1):219-232. PubMed ID: 27639393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular inhibitory mechanism of dihydromyricetin on mushroom tyrosinase.
    Chen J; Liu S; Huang Z; Huang W; Li Q; Ye Y
    J Biomol Struct Dyn; 2018 Nov; 36(14):3740-3752. PubMed ID: 29067862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of thiazolidinone derivatives as a new class of mushroom tyrosinase inhibitors.
    Rezaei M; Mohammadi HT; Mahdavi A; Shourian M; Ghafouri H
    Int J Biol Macromol; 2018 Mar; 108():205-213. PubMed ID: 29180052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical exploration of 4-(4-fluorobenzyl)piperidine fragment for the development of new tyrosinase inhibitors.
    Ferro S; De Luca L; Germanò MP; Buemi MR; Ielo L; Certo G; Kanteev M; Fishman A; Rapisarda A; Gitto R
    Eur J Med Chem; 2017 Jan; 125():992-1001. PubMed ID: 27810600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.